Neoplasms
Showing NaN - NaN of 63
Tumors, Esophageal Tumors, Esophagus Tumor Trial run by the National Cancer Institute (NCI) (Nivolumab, Entinostat, Montanide(R)
Not yet recruiting
- Neoplasms
- +5 more
- Nivolumab
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jun 16, 2023
Respiratory Tract Diseases, Tumors, Tumors by Histologic Type Trial run by the National Cancer Institute (NCI) (Bevacizumab)
Not yet recruiting
- Respiratory Tract Diseases
- +14 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Apr 10, 2023
Clinical and Genetic Studies of Li-Fraumeni Syndrome
Recruiting
- Li-Fraumeni Syndrome
- +2 more
-
Bethesda, Maryland
- +1 more
Jan 25, 2023
Tumors Trial run by the National Cancer Institute (NCI) (FdCyd + THU)
Completed
- Neoplasms
- FdCyd + THU
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 24, 2023
Collection of Tissue Samples for Cancer Research
Recruiting
- Neoplasms
- +3 more
- Biopsy
-
Atlanta, Georgia
- +9 more
Jan 23, 2023
Tumors, Solid Tumors Trial run by the National Cancer Institute (NCI) (aza-TdC)
Recruiting
- Neoplasms
- Solid Tumors
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Tissue Specimens From Solid Tumors or Blood Disorders and Their
Recruiting
- Neoplasms
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 21, 2023
Tumors Trial run by the NCI (Nilotinib and Paclitaxel)
Recruiting
- Neoplasms
- Nilotinib and Paclitaxel
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 19, 2023
NSCLC, NSCLC, Carcinoma, Bronchogenic Trial in United States (furmonertinib 240 mg, furmonertinib 160 mg, platinum-based chemo)
Recruiting
- Non-Small Cell Lung Cancer
- +13 more
- furmonertinib 240 mg
- +2 more
-
Yuma, Arizona
- +37 more
Dec 14, 2022
Tracking for the Developmental Therapeutics Clinic
Recruiting
- Neoplasms
- Lymphoma
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Dec 9, 2022
Data Collection, Clinical Care and Interventions in CCR, NCI
Enrolling by invitation
- Neoplasms
- Cancer
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 20, 2022
Omics of Cancer: OncoGenomics
Not yet recruiting
- Neoplasms
- Cancer
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 17, 2022
Tumors, Solid Tumors Trial run by the NCI (TdCyd)
Suspended
- Neoplasms
- Solid Tumors
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 6, 2022
Tumors Trial in Worldwide (Gene-modified (GM) T cell therapy)
Recruiting
- Neoplasms
- Gene-modified (GM) T cell therapy
-
Birmingham, Alabama
- +173 more
Aug 1, 2022
Mobile Sensor Technologies to Assess General Symptomology of
Enrolling by invitation
- Neoplasms
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 20, 2022
Tumors, Pancreatic Tumors Trial run by the NCI (LMB-100, Nab-Paclitaxel, Mesothelin Expression)
Completed
- Neoplasms
- Pancreatic Neoplasms
- LMB-100
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 16, 2022
Carcinoma, Endometrial Adenocarcinoma, Tumors Trial in United States (PEN-866 Sodium, fluorouracil, Folinic acid)
Recruiting
- Carcinoma
- +18 more
- PEN-866 Sodium
- +3 more
-
Springdale, Arkansas
- +15 more
Feb 16, 2022
Tumors Trial in Bethesda, Boston, Houston (Veliparib + VX-970 + Cisplatin)
Completed
- Neoplasms
- Veliparib + VX-970 + Cisplatin
-
Bethesda, Maryland
- +2 more
Jan 14, 2022
Tumors Trial in Worldwide (GSK adoptive cell therapy)
Recruiting
- Neoplasms
- GSK adoptive cell therapy
-
Duarte, California
- +37 more
Feb 1, 2022
Tumors Trial in United States (NY-ESO-1(c259)T Cells, Fludarabine, Cyclophosphamide)
Completed
- Neoplasms
- NY-ESO-1(c259)T Cells
- +2 more
-
Duarte, California
- +7 more
Jun 9, 2021
Sarcoma, Stomach Tumors, Tumors Trial run by the NCI (Pazopanib, ARQ 197)
Completed
- Sarcoma
- +2 more
- Pazopanib
- ARQ 197
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 23, 2021
Clinical Sequencing of Cancer and Tissue Repository:
Withdrawn
- Neoplasms
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 7, 2020